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Abstract
Background: Fibromyalgia (FM) is a pain syndrome, the mechanisms and predictors of which are still unclear. We
have earlier validated a set of FM-symptom questions for detecting possible FM in an epidemiological survey and
thereby identified a cluster with “possible FM”. This study explores prospectively predictors for membership of that
FM-symptom cluster.
Methods: A population-based sample of 8343 subjects of the older Finnish Twin Cohort replied to health questionnaires
in 1975, 1981, and 1990. Their answers to the set of FM-symptom questions in 1990 classified them in three latent classes
(LC): LC1 with no or few symptoms, LC2 with some symptoms, and LC3 with many FM symptoms. We analysed putative
predictors for these symptom classes using baseline (1975 and 1981) data on regional pain, headache, migraine, sleeping,
body mass index (BMI), physical activity, smoking, and zygosity, adjusted for age, gender, and education. Those with a
high likelihood of having fibromyalgia at baseline were excluded from the analysis. In the final multivariate regression
model, regional pain, sleeping problems, and overweight were all predictors for membership in the class with
many FM symptoms.
Results: The strongest non-genetic predictor was frequent headache (OR 8.6, CI 95 % 3.8–19.2), followed by
persistent back pain (OR 4.7, CI 95 % 3.3–6.7) and persistent neck pain (OR 3.3, CI 95 % 1.8–6.0).
Conclusions: Regional pain, frequent headache, and persistent back or neck pain, sleeping problems, and
overweight are predictors for having a cluster of symptoms consistent with fibromyalgia.
Background
Fibromyalgia (FM) is today better understood and recog-
nised than 25 years ago, when the classification criteria
for FM were first published [1]. These criteria are: (1) A
history of widespread pain (WSP) (pain on the left and
right sides of the body, above and below the waist, and
axial skeletal pain); (2) pain on palpation of at least 11 of
18 specified sites. Until then, the syndrome was ill-
defined, with its very existence questioned by many.
Even now, we do not still fully understand the reasons
for the development of FM and its symptoms, which
makes prevention impossible.
Prospective population-based studies on the incidence
and predictors of FM are few, whereas many cross-
sectional and tertiary clinic studies assess predictors. In a
cross-sectional setting, the sequential relationship remains
unclear, and one can only identify an association, not a
prediction. Among tertiary care patients, selection bias
may significantly alter the profile and aggregation of pre-
dictors. So far, the few prospective population-based stud-
ies on the incidence and predictors of FM or widespread
pain have focused on one or a few potential predictors.
Regional back pain as well as depressive tendencies pre-
dicted WSP in schoolchildren [2] and FM in adults [3].
Another rather small study revealed higher age and mul-
tiple pain sites at baseline to be risk factors for WSP [4].
One prospective population-based study indicated an in-
dependent association between a high BMI and risk for
FM. In the same study, leisure-time physical exercise level
and future FM tended towards a weak inverse dose–re-
sponse association [5]. Sleep disturbance is associated with
increased sensitivity to noxious stimuli and with chronic
pain intensity level [6–9]. Two large prospective studies
revealed an association between poor sleep and FM [10]
or WSP [11], the latter also showing association between
low BMI, anxiety, depression and WSP.
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Genetic differences accounted for approximately
50 % of the variability of FM-associated symptoms in
our large twin-population-based cross-sectional sample,
using a latent class approach for symptom classification
[12]. Moreover, many disease-related predictors have a
genetic component reflecting individual genetic differ-
ences in the propensity to acquire the predictor (such as
smoking, alcohol use) or the propensity in the degree to
which it is expressed (such as education or physical activ-
ity). This has been shown by family and twin studies, and
increasingly confirmed by genome-wide association stud-
ies. Thus, genetic factors shared by FM and putative pre-
dictors may also generate an association without being
causal. Studies of trait-discordant twin pairs (i.e. one co-
twin has a trait, and the other does not) permit controlling
of such genetic confounds by examining within-pair asso-
ciations of the predictor and future disease. Twins share
their genetic background, either fully (monozygotic twins)
or in 50 % of their segregating genes (dizygotic twins). In
addition, twins usually also share family and childhood
exposures.
The aim of this study was to evaluate simultan-
eously, in a population-based large prospective twin
cohort, several potential predictors for fibromyalgia
and possible genetic confounds, these factors having




The study population is based on the Finnish Twin
Cohort, which consists of twin pairs born before
1958, with both twins alive in 1975, at the time of
the first cohort-wide health questionnaire [13]. A sec-
ond cohort-wide health questionnaire was sent in
1981, and a follow-up questionnaire was mailed in
1990 to the 16,179 twins born in 1930–1957 who had
replied to either of the previous questionnaires. Of
these twins, 12,502 subjects (77.3 %) responded [14].
For the first two questionnaires, response rates were
89 and 84 %, respectively.
The study is limited to questionnaire and anon-
ymised medical record data, for which permission
from the relevant authorities has been sufficient. The
use of the questionnaire data for record linkage stud-
ies has been approved by the ethics committee of the
Department of Public Health, University of Helsinki.
The twin cohort members were informed about the
use of the questionnaire information to study genetic
and environmental influences on common diseases
and their predictors and also about the record link-
age, and been informed that they may withdraw from
the study at any time.
The screening method for an epidemiological estimation
of subjects with potential fibromyalgia
In our earlier study [12], based on the 1990 survey data,
we classified these subjects into three latent symptom
classes based on their answers to certain questions aim-
ing to detect fibromyalgia. The latent class (LC) analysis
is a statistical system which classifies data in categories
that are internally as homogeneous and externally as
heterogeneous as possible in relation to specific qual-
ities, in this case to these FM-questions. From the ori-
ginal survey questions based on the Yunus et al. criteria
suggestions from 1989 [15], we chose these questions
about FM symptoms and FM-associated symptoms
(from now on all called FM symptoms) according to the
American College of Rheumatology 1990 classification
criteria [1]. The questions were: How often have you had
these symptoms during the last year? 1) stiffness in the
limbs and trunk in the morning, 2) stiffness in the limbs
and trunk in the evening, 3) pain and stiffness in the
neck, 4) soreness with touching of the neck, back, trunk,
or limbs, 5) numbness in the extremities, 6) daytime
tiredness. 7) Does the stiffness in the limbs and trunk in
the morning last “less than 15 min”, “about half an
hour”, or “about 1–2 h”? and 8) Does low air pressure
(rain, snow, storm) worsen the pain in the trunk or
limbs?
Questions 1 to 6 were provided with the alternatives
“never”, “daily or nearly daily”, “3–5 times per week”,
“1–2 times per week”, “about once a month”, and “more
seldom”. Exclusion of subjects with missing data con-
cerning these classification questions yielded 10,608 sub-
jects. Three latent classes represented the subjects best:
LC1 indicated no or few symptoms; LC2 had some
symptoms; and LC3 had a high frequency of FM symp-
toms resembling clinical FM patients. In LC3, over 80 %
of the subjects had morning stiffness, 58 % had tender
points, 65 % had neck pain and stiffness, and 48 % had
daytime tiredness at least three times a week.
We also used the answers of a group of 49 clinically-
diagnosed FM patients [12] as a validation data set. The
LC method described classified all clinical FM patients
to LC3 [12].
Exclusions
In the present study, we aimed to identify predictors of
onset of LC2 and, in particular, LC3 memberships, i.e.
predictors of the high incidence of FM symptoms as a
proxy for WSP (widely used as a screening method) and
FM. As these symptoms were not assessed in the 1975
and 1981 questionnaires, we used available information
on pain-associated conditions to exclude those who
would very likely be classified into LC2 or 3 as shown in
the flowchart (Fig. 1). Thus, we first excluded the
subjects having inflammatory rheumatic diseases or
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malignancies (which might cause the symptom load) by
linking the data with national Special Refund Category
data in the Drug Reimbursement Register held by the
Social Insurance Institution and with data on incident
cancers from the Finnish Cancer Registry to 1993. Sub-
jects with missing data concerning particular regional
pain questions either in 1975 or 1981 were excluded.
We then excluded the subjects with possible FM symp-
toms at baseline by excluding those who reported pain
in the neck and shoulders and back at the same time, in
either 1975 or 1981 (this served as a proxy for pain at
multiple sites, referred to as “WSP” in Fig. 1). Earlier, we
had shown that regular use of analgesics was almost en-
tirely restricted to the LC3 subjects. Therefore we also
excluded those who reported having used analgesics of
that frequency (on at least 180 days per year) in either
1975 or 1981 (Fig. 1). The final baseline sample for ana-
lysis, i.e. the population at risk, we presumed to be free of
pain at multiple sites and free of major conditions giving
rise to similar symptoms.
Study variables
We selected the variables analysed as potential predic-
tors based on reports in the literature on putative pre-
dictors; that is, variables that had positive associations
with FM or WSP in either cross-sectional or prospective,
population-based, qualified studies mentioned in this
article [2–11]. These included separate regional pain
Fig. 1 Flow chart of the study. WSP widespread pain
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symptoms, headache, migraine, sleeping, underweight,
overweight or obesity as indexed by BMI, smoking, and
physical activity.
These potential predictors were assessed as follows. A
simple question “In the last years, have you had pain in
the back, shoulders, or neck that has impaired your
working capacity?” with the alternatives “yes” and “no”
for each region, assessed regional pain symptoms. The
occurrence of migraine was based on the subjects’ report
of diagnosed migraine [16]. The occurrence and fre-
quency of headache was assessed in 1981 only by the
question “Do you have headache?” with the options
“daily or almost daily”, “many times a week”, “about
once in a week”, “about once a month”, “many times in
a year (but not every month)”, “once in a year or less”
and “practically never” (reference category) [16]. An-
other question was “Do you usually sleep well?” with the
options “well”, “fairly well”, “fairly badly”, “badly”, and
“cannot answer” [17]. As the number of individuals
reporting sleeping “badly” at baseline was small (36 and
52 in 1975 and 1981), we merged the two first alterna-
tives into the category “good sleep” (reference category)
and the next two into “poor sleep”. The number of “can-
not answer” replies was also small (44 and 48 in 1975
and 1981) and they were handled as missing data.
The self-reported height and weight in both 1975 and
1981 produced BMI values which were classified in four
categories based on WHO criteria: at least 30 (obese), at
least 25 but less than 30 (overweight), under 18.5
(underweight), and at least 18.5 but under 25 (normal
weight, reference category).
Two questions were on leisure-time physical activity.
The question about year-round leisure-time activity, with
the alternatives 1) “I do not exercise in my leisure time
practically at all”, 2) “a bit”, 3) “fairly”, 4) “fairly much” and
5) “much”, originally assessed physical activity. As we
wanted to look at physical passivity as a possible predictor
and activity as a potential protecting factor, we re-
classified these replies into three categories: physically
passive (1–2), physically active (4–5), and average (3),
which was used as a reference. Leisure-time exercise
frequency was originally assessed by the alternatives 1) less
than once, 2) 1–2 times, 3) 3–5 times, 4) 6–10 times, 5)
11–19 times, and 6) more than 20 times a month [18]. For
this study we re-categorised these as three alternatives: 1)
at most twice, 2) 3–10 times (reference category), and 3)
at least 11 times a month. For smoking status, the subjects
were classified into four groups: current smoker, former
smoker, occasional smoker, and non-smoker (reference
category) [19].
Reported gender, age (calculated from registry data
and the date of response to the query), and education
presented potential confounders. Education was origin-
ally reported with nine alternatives from elementary
school to college or university degree. For this study, we
calculated the mean of the education years for each al-
ternative to form a continuous variable.
Zygosity was diagnosed by a validated questionnaire
method using questions on similarity in appearance and
confusion by strangers [20].
Statistical analysis
Two sets of analyses were conducted, first among all in-
dividuals (as a standard cohort analysis) and secondly
within twin pairs to adjust for unmeasured genes and
other factors shared by siblings.
Cohort analysis of individuals
For the analysis of potential predictors for FM symptoms
among individuals, we used multinomial logistic regression
analysis with the three latent symptom classes as the cat-
egories of the dependent variable. The asymptomatic class,
LC 1, served as the reference category. As potential predic-
tors, we analysed back pain, neck pain, shoulder pain, head-
ache (data available only from 1981), migraine (data
available only from 1981), sleeping problems, physical pas-
sivity or activity, BMI, and smoking, using the information
from 1975 to 1981. The bivariate associations were first
tested with logistic regression analysis, adjusting for age
and gender. Based on these analyses, (i.e. including those
variables with significant associations), we performed multi-
variate logistic regression analyses, adjusted for gender, age,
and education. These variables were taken forward to the
within family, i.e. pairwise analyses described below.
Before the pairwise analyses, we used the standard cohort
approach to test for any possible moderation effect. We
thus included interaction terms for gender, age, and educa-
tion in the analysis with the data stratified by gender (men
vs. women), age (under vs. over the median age), and edu-
cation (high-school education, yes vs. no).
Post-hoc analysis of individuals
To analyse whether the persistence or recurrence of re-
gional pain (back, shoulder, and neck pain) had any ef-
fect on the association with the future symptom class,
we made re-analyses in a sub-sample with those individ-
uals who had replied to the questionnaires both in 1975
and 1981, comparing positive reports at both time points
(persistent or recurrent pain) to positive–negative com-
binations (pain at only one time point) and negative
reports at both time points (no pain) in all three regions.
We did an additional analysis considering only those
with more recent pain onset by inclusion of those sub-
jects reporting no pain (back, shoulder, or neck) in 1975.
Within-pair analysis
The second set of analyses used the information on
twinship to assess the possible effect of genetic or
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familial environmental factors on the relationship be-
tween predictors and FM symptoms. We identified the
twin pairs discordant for “latent class” status, i.e. pairs in
which one twin was classified as LC3 and the co-twin as
LC1. If the genetic or environmental factors shared by
the twin pair could account for the relationship between
predictors and FM symptoms, the risk (the ORs) would
presumably decrease. If particularly the genetic factors
could account for the relationship, some association would
appear in dizygotic (DZ) twins (who share on average 50 %
of their segregating genes) but not in monozygotic (MZ)
twins (who have an identical genotype) [21]. For this assess-
ment, we used conditional logistic regression analysis. The
predictors that were significant in the multivariate model
were all included in this analysis.
Statistical software
We used the Stata version 12 in the pairwise analyses; in
all other analyses we used SPSS version 19.
Results
The original sample without missing data after excluding
those fulfilling the disease exclusion criteria (inflamma-
tory rheumatic diseases and malignancies) consisted of
9656 individuals, of which 46.2 % were men and 53.8 %
women. Of these individuals, 11.7 % were classified in
1990 into latent class 3 (with a high frequency of FM
symptoms). In 1975, 4.6 % individuals reported pain in
both back, shoulders, and neck, and in 1981 this propor-
tion was 10.1 %. After exclusion of these subjects with
possible FM symptoms and those with frequent use of
analgesics at the baseline, we had a final sample of 8343
subjects (Fig. 1).
The final sample comprised 3946 (47.3 %) men and
4397 (52.7 %) women, with an overall mean age in 1975
of 27.7 ± 7.3 years. Some gender differences for the co-
variates emerged as expected. All subsequent analyses
were adjusted for gender.
In 1990, 700 individuals (8.4 %) in this sample were
classified into latent class 3 with a high frequency of
FM symptoms, 2501 individuals (30.0 %) into latent
class 2 with some symptoms, and 5142 individuals
(61.6 %) into latent class 1 with no or few symptoms.
Baseline characteristics in terms of the potential pre-
dictor variables of this study varied across these latent
classes from LC1 to LC3: the frequency of all of the
proposed predictors increased, whereas the mean
value of the confounding factor education decreased
(Additional file 1).
Cohort analysis of individuals
In the univariate regression analyses adjusted for age
and gender, all of the proposed predictors significantly
predicted membership in the high-frequency symptom
class. Therefore, all the variables were included in the
multivariate analysis. In the final multivariate model, how-
ever, only regional pain problems, sleeping problems, and
overweight remained significant predictors (Table 1 and
Additional file 2). A nearly constant “dose response” is evi-
dent with regard to the statistically significant predictors,
because the predictors were more strongly associated with
LC3 than with LC2.
While two of the age group-regional-pain interaction
comparisons were nominally significant at the p < 0.05
level, neither survived adjustment for multiple testing,
given that we had no a priori hypothesis that such inter-
actions existed specifically for any predictor. Thus, we
have no evidence that predictive value varies by level of
these three covariates.
Most of the subjects in this sample, 5894 individ-
uals, had replied to the questions concerning regional
pain in the back, neck, or shoulders both in 1975 and
in 1981, with most of the missing data in 1981
(Table 1). Of these individuals, 86.9 % reported no
neck pain, 87.9 % reported no shoulder pain, and
74.1 % no back pain at either time point, whereas
5.9 % (349 individuals) reported back pain, 2.1 % (123
individuals) neck pain, and only 1.5 % (89 individuals)
shoulder pain at both time points. These individuals
may represent those with persistent regional pain. In
the univariate analyses of this sub-sample, persistent
regional pain in either back, neck, or shoulder was
about twice as powerful a predictor of FM symptoms
as was transient pain (Table 2). Only frequent head-
ache was a stronger predictor than was persistent
regional pain. Current smoking in 1981 was a signifi-
cant predictor as well. In the multivariate analyses of
1981, poor sleep (OR = 2.23, 95 % CI 1.39–3.58) and
high BMI (obesity OR = 1.72, 95 % CI 0.94–3.2 and
overweight OR = 1.55, 95 % CI 1.17–2.05) remained
predictors (data not shown). Headache remained a
strong predictor with no change in the odds ratios,
when the persistent regional pain variables were taken
into the model.
The exclusion of all individuals who reported any
pain in either back, shoulder, or neck in 1975 left
5691 individuals. Only 4.8 % of these were later clas-
sified in LC3. This diminished the ORs of the re-
gional pain variables from 1981, including headache,
in the multivariate analysis. Regional back pain, sleep
problems, overweight, and headache, however, still
remained significant predictors. The OR for frequent
headache diminished from 7.10 to 5.01 and for back
pain from 2.99 to 2.32; other changes in OR esti-
mates varied by 20 % at most. In the univariate ana-
lyses, all variables except exercise frequency were
significant. The amount of missing answers ranged
from 4 to 16 %.
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Within-pair analysis
In the main analysis sample (of 8434 individuals) were
2345 twin pairs, of which 802 were monozygotic (MZ),
1401 dizygotic (DZ); 142 pairs had uncertain zygosity,
and 3653 individual twins were without their co-twins
(due to non-response or exclusion criteria). There were
only 161 twin pairs discordant for their classification in
LC3 vs. LC1. Of these pairs, 33 were MZ, 118 DZ, and
10 were uncertain-zygosity pairs. Significant associations
of predictors with symptom class within pairs were
evident for headache, back, neck, and shoulder pain, but
not for BMI, sleep quality, or education (Table 3). If the
association between the presumed predictor and classifi-
cation in LC3 depended on familial factors, no associ-
ation (or at least one much weaker) would exist in this
analysis between the predictor variable and LC3. If the
association depended specifically on genetic factors, we
would presumably find some association among the DZ
pairs (who share approximately 50 % of their genes) but
not in the MZ pairs (with an almost identical genotype).
Table 1 Predictors of fibromyalgia symptoms: multivariate analyses
OR (95 % CI) for LC2 1975
variable data




OR (95 % CI) LC2
1981 variable data




age (years) 1.02 (1.01–1.03) 1.06 (1.05–1.07) 8343 1.02 (1.01–1.03) 1.06 (1.05–1.08) 8343
gender (female/male) 1.34 (1.20–1.50) 1.41 (1.17–1.70) 8343 1.08 (0.94–1.23) 1.16 (0.89–1.49) 8343
back pain (yes/no) 1.56 (1.38–1.76) 2.26 (1.88–2.72) 8149 1.73 (1.47–2.04) 2.99 (2.31–3.88) 7281
shoulder pain (yes/no) 1.42 (1.14–1.77) 1.84 (1.36–2.49) 8146 1.77 (1.41–2.21) 1.75 (1.23–2.48) 6636
neck pain (yes/no) 1.94 (1.60–2.35) 2.34 (1.79–3.07) 8144 1.23 (0.98–1.54) 1.76 (1.26–2.46) 6718
poor sleep 1.27 (0.96–1.66) 1.78 (1.22–2.60) 1.58 (1.17–2.14) 2.34 (1.49–3.67)
good sleep 1.00 (reference category) 1.00 8116 1.00 1.00 7966
BMI (kg/m-squared)
≥ 30 1.19 (0.78–1.80) 1.86 (1.09–3.17) 1.19 (0.81–1.76) 1.65 (0.91–3.01)
25–29.9 1.20 (1.03–1.40) 1.60 (1.28–1.99) 1.32 (1.12–1.56) 1.67 (1.27–2.20)
18.5–24.9 1.00 (reference category) 1.00 1.00 1.00
< 18.5 0.80 (0.64–1.00) 0.86 (0.55–1.33) 8056 0.62 (0.44–0.88) 0.56 (0.25–1.25) 7913
education (years) 0.96 (0.94–0.97) 0.86 (0.83–0.90) 8134 0.97 (0.95–0.98) 0.89 (0.85–0.92) 7754
physical activity
passive 0.94 (0.83–1.07) 1.15 (0.93–1.43) 1.04 (0.90–1.21) 1.08 (0.82–1.41)
moderate 1.00 (reference category) 1.00 1.00 1.00
active 0.90 (0.76–1.08) 1.00 (0.73–1.38) 8148 0.88 (0.72–1.08) 0.87 (0.58–1.30) 8007
exercise frequency/month
1–2 times 1.02 (0.90–1.16) 0.98 (0.79–1.20) 0.96 (0.82–1.13) 0.94 (0.70–1.26)
3–10 times 1.00 (reference category) 1.00 1.00 1.00
> 11 times 0.856 (0.74–1.00) 0.91 (0.69–1.18) 7889 1.01 (0.85–1.20) 1.01 (0.73–1.40) 7849
smoking
current 1.10 (0.97–1.24) 1.20 (0.98–1.47) 1.11 (0.95–1.29) 1.21 (0.91–1.59)
former 1.14 (0.98–1.32) 0.97 (0.75–1.25) 1.05 (0.90–1.24) 0.95 (0.70–1.30)
occasional 1.27 (0.97–1.66) 0.90 (0.53–1.52) 1.12 (0.79–1.58) 0.83 (0.40–1.72)
never 1.00 (reference category) 1.00 8146 1.00 1.00 7936
migraine (yes/no) n.a. n.a. 0.86 (0.68–1.08) 1.17 (0.82–1.67) 7986
headache frequency n.a. n.a.
many /week 3.35 (2.19–5.13) 7.22 (4.03–12.95)
1–4 /month 1.95 (1.62–2.35) 2.22 (1.56–3.15)
some/year 1.64 (1.40–1.93) 1.64 (1.19–2.26)
never 1.00 (ref. category) 1.00 7767
The reference category for the outcome is LC1, i.e. those with no or very few fibromyalgia symptoms [12]. Odds ratios and 95 % confidence intervals are provided
for LC2 (with some fibromyalgia symptoms) and LC3 (with many fibromyalgia symptoms), based on latent class (LC) analyses in 1990. Predictors are assessed from
data collected in 1975 and 1981 with the exception of migraine and headache frequency from 1981 only
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The associations were generally equally strong in DZ
pairs analysed alone, but with some loss of statistical
significance due to smaller sample sizes. In MZ pairs,
the effects were generally greatly attenuated, and none
of the associations within pairs are significant.
Discussion
In this simultaneous analysis of several potential predic-
tors for membership in a latent class characterized by
having multiple symptoms of fibromyalgia, the strongest
predictor was headache, with a dose-dependent effect.
Table 2 Predictors for fibromyalgia symptoms in the sub-sample with regional pain data from both 1975 and 1981 (5894 individuals)
Univariate analysesa Multivariate analyses
OR (95 % CI) for LC3 OR (95 % CI) for LC3 1975 variable data OR (95 % CI) for LC3 1981 variable data
n = 374 “cases”/ 5894 persons n = 353 “cases” n = 346 “cases”
headache frequency 1981 not assessed
many /week 11.33 (6.63–19.35) 6.79 (3.73–12.37)
1–4 /month 2.66 (1.91–3.69) 2.06 (1.44–2.94)
some/year 1.78 (1.31–2.41) 1.53 (1.11–2.13)
never 1.00 (reference category) 1.00
back pain (yes/no)
both 1975 and 1981 6.33 (4.55–8.81) 5.20 (3.67–7.38) 4.67 (3.28–6.67)
either 1975 or 1981 2.28 (1.77–2.94) 1.97 (1.51–2.59) 1.85 (1.41–2.44)
never 1.00 (reference category) 1.00 1.00
shoulder pain (yes/no)
both 1975 and 1981 4.65 (2.41–8.97) 2.10 (1.02–4.34) 1.89 (0.89–4.02)
either 1975 or 1981 2.38 (1.77–3.19) 1.56 (1.12–2.16) 1.51 (1.08–2.12)
never 1.00 (reference category) 1.00 1.00
neck pain (yes/no)
both 1975 and 1981 5.78 (3.42–9.75) 3.80 (2.11–6.83) 3.32 (1.83–6.02)
either 1975 or 1981 2.23 (1.66–2.99) 1.69 (1.22–2.33) 1.51 (1.09–2.09)
never 1.00 (reference category) 1.00 1.00
The reference category for the outcome is LC1, i.e. those with no or very few fibromyalgia symptoms [12]. Odds ratios and 95 % confidence intervals are provided
for LC3 (with many fibromyalgia symptoms), based on latent class (LC) analyses in 1990. Predictors are assessed from data collected in 1975 and 1981 with the
exception of headache frequency, which was only from the 1981 survey
aadjusted for age and gender
Table 3 Pairwise analyses of odds ratios (with 95 % confidence intervals) for future classification in latent class 3 (LC3) with FM
symptoms (in 1990) in twin pairs discordant for this classification (LC3 vs. LC1). Predictors are assessed from 1981
Predictor Odds ratios (with 95 % confidence intervals) for LC3 by zygosity
All discordant twin pairs Dizygotic twin pairs Monozygotic twin pairs
OR (95 % CI) n OR (95 % CI) n OR (95 % CI) n
back pain (yes/no) 2.7 (1.4–5.2) 117 2.3 (1.1–4.6) 86 5.0 (0.6–42.8) 23
shoulder pain (yes/no) 3.1 (1.3–7.4) 91 8.0 (1.8–34.8) 64 1.0 (0.3–3.5) 23
neck pain (yes/no) 4.0 (1.5–10.7) 92 5.0 (1.4–17.3) 64 2.0 (0.4–10.9) 24
poor sleep 1.4 (0.4–4.4) 144 1.3 (0.3–6.0) 104 1.5 (0.3–9.0) 31
good sleep 1.0 reference category 1.0 1.0
BMI 143 103 31
overweight 1.9 (1.0–3.8) 1.6 (0.8–3.3) 5.0 (0.6–42.8)
underweight 0.5 (0.0–5.5) 0.5 (0.0–5.5) omitteda
normal weight 1.0 reference category 1.0 1.0
headache (yes/no) 2.1 (1.0–4.1) 132 2.2 (1.0–4.9) 97 2.5 (0.5–12.9) 27
n number of twin pairs discordant for each variable, LC3 those with many fibromyalgia symptoms, LC1 those with no or few fibromyalgia symptoms
Sums of dizygotic and monozygotic pairs do not equal the sums of all discordant twin pairs, because the zygosity of some pairs remained uncertain
aNumber of individuals in this category was too small for an adequate analysis
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Other predictors were back and neck pain, overweight,
and sleep problems in this prospective follow-up of a
large cohort of adults from the Finnish Twin Cohort,
analysed both as individuals and through within-pair
analyses.
A strong association between headache and FM has oc-
curred in one cross-sectional study as well, particularly be-
tween chronic migraine and chronic tension-type headache
(TTH) [22]. A recent large, prospective, population-based
study found a bi-directional relationship between chronic
daily headache and chronic musculoskeletal complaints
(CMSC). In that study, headache at baseline produced a
greater risk for widespread CMSC than for non-widespread
CMSC [23]. The prevalence of migraine reported in our
study is comparable with that of other epidemiological
studies [24, 25], and the assessment may therefore be con-
sidered reliable. Moreover, a self-report of physician-
diagnosed major chronic disease has high validity compared
to medical records [26]. Migraine, however, failed to predict
FM symptoms. We have no knowledge of the persistence
of headache in this group, as the occurrence was assessed
only in 1981. Reports of a headache frequency as “daily or
nearly daily” or “several times per week” refer to a chronic
condition, however. Chronic TTH (referring to our head-
ache category with the highest frequency) may lead to cen-
tral sensitisation with increased peripheral multi-modal
pain sensitivity in skin, muscle, and peripheral nerves [27].
Generalised muscular hyperalgesia is seen in frequent epi-
sodic TTH, as well [28].
For TTH, the most commonly reported precipitant is
psychological distress [29], while non-specific headache
associates with numerous work-related stressors [30].
Long-lasting stressors elevate cytokine levels [31] and
cytokines may play a role in the activation of trigger
points and in peripheral sensitisation in FM [32–35]. In
several studies, treatment of co-occurring trigger points
has alleviated generalised pain in FM [36].
Overweight or obesity magnified the risk for FM
symptoms markedly depending on the time of the pro-
spective evaluation and the level of the BMI. A mediator
of the effect of overweight may be inflammatory activity
of the adipose tissue, causing peripheral sensitisation
[37, 38]. Probably other mediators exist as well. Another
connection between overweight and FM symptoms may
be over-activation of the stress system leading to sleep
problems and weight gain. Higher stress levels may also
be a consequence of stigmatisation in society. Numerous
studies have shown an association between psychological
distress and subpopulations of FM patients [39–42], but
the causal relationship may be bi-directional. This may
also be the case with perturbations of the stress system
(hypothalamic-pituitary-adrenal axis and autonomic ner-
vous system) [43]. In this study, there was no association
between underweight and FM symptoms, while in the
HUNT study it was associated with increased risk for
chronic WSP [11].
This may be due to the low frequency of underweight
subjects in our cohort.
Back pain was a strong predictor, consistent with the
results of Forseth and colleagues (1999) and Mikkelsson
and colleagues (2008) who studied schoolchildren [2, 3].
As in this study of FM symptoms, local or regional pain
states have also proven to be predictors for widespread
pain [44]. Repetition of pain stimuli in human pain ex-
periments also leads to increased pain and an enlarged
pain area. Chronic pain is related to deficient top-down
modulation of pain [45]. Theoretically, long-lasting re-
gional pain could lead to central sensitisation and to
widening of the painful area. Indeed, in further analyses,
we found that the groups with persistent, either chronic
or recurrent, regional pain produced even greater ORs
for FM symptoms. These findings are in concordance
with the generalised deep-tissue hyperalgesia in patients
with chronic low-back and radiating pain after disc her-
niation [46] and with the generalised mechanical allody-
nia in patient groups with various types of chronic pain
[47]. Moreover, when we excluded the subjects reporting
any pain in 1975, the proportion of individuals later clas-
sified into LC3 dropped markedly. This suggests slow
development over years if not over decades of the FM
symptoms and strengthens the finding of the predictive
role of regional pain. The increasing predictive power of
the pain variables when representing persistent pain
agrees well with the central sensitisation theory.
Given the association of sleep disturbance and pain, the
effect of sleeping poorly on future risk for FM symptoms
was expected and is in concordance with the studies of
Mork and Nilsen [10] and Mundal and colleagues [11].
Sleep disturbances also associate with headache [29, 48]
and psychological distress in many ways [49, 50].
Conversely to our expectations and to the study of Mork
and colleagues (2010) [5], we found no relationship be-
tween exercise and FM symptoms. At baseline, subjects in
the future high-symptom class were more passive than in
the other two classes. In bivariate analyses, both the re-
ported physical activity and reported exercise frequency re-
duced OR for FM symptoms, but no dose response
appeared either in the reported exercise classification or in
a more detailed quantitative classification (data not shown).
We found no such relationship when analysing the genders
separately, either. A reason for this discordance might be
that our final sample was smaller than in the study of Mork
and colleagues. Second, the dependent variables differed.
Third, our primary exercise parameters may be insuffi-
ciently accurate. Lastly, other, more powerful variables, re-
gional pain variables and sleep (not included in Mork’s
study), diminished the effect of exercise factors in multi-
variate analyses.
Markkula et al. BMC Musculoskeletal Disorders  (2016) 17:29 Page 8 of 11
We earlier showed an additive genetic effect behind
the distribution of the original twin sample in three FM
symptom classes. The small number of discordant pairs
and decreasing proportion of MZ pairs among them
(compared to the whole sample) are therefore logical.
Pain variables associated significantly with future FM-
symptoms also within twin pairs. We cannot, however,
exclude the predictive power of regional pain problems
as being partly dependent on genetic factors. None of
the associations in MZ pairs were significant – perhaps
due both to insufficient statistical power and to full ad-
justment for genetic background. For headache and back
pain, MZ point estimates are of the same magnitude as
in DZ pairs and in all pairs, consistent with an associ-
ation with FM-like symptoms independent of family
background and genes.
Strengths of this study are the large study population
with a relatively good response rate, the prospective set-
ting with a 9- to 15-year follow-up, and the possibility of
analysing many relevant predictors simultaneously. Un-
fortunately, no pain drawing was included in the three
questionnaires, so results are not directly comparable
with studies on widespread pain. Despite this, and the
lack of an FM-question battery before 1990, we were
able to make exclusions at baseline on the basis of re-
ported regional pain at multiple sites and frequent anal-
gesic use. The proportion of excluded subjects (13.6 %)
reflected the generally estimated WSP prevalence quite
well. Moreover, the exclusions, based on other pain as-
sessments in 1975–1980, diminished the proportion of
the future FM symptom class by approximately 30 %.
Analyses of the subpopulation with no reported pain in
either neck, shoulders, or back (and thus with no wide-
spread pain) in 1975 yielded marginally smaller odds ra-
tios for new-onset regional pain.
The two baseline questionnaires from 1975 to 1981 un-
fortunately included no assessment of anxiety, though it is
connected variously with pain [51–53] and would have
been valuable to investigate as a possible predictive factor.
Nor did we have a formal assessment of depression at
baseline. Two recent large prospective population-based
studies revealed that anxiety was associated with new-
onset WSP [11, 54], while depression had a weaker associ-
ation in one of them [11] and no association in the other
among older adults [54]. However, there is also evidence
that depression would follow rather than precede pain
[55, 56]. Features such as sensitivity to distress and adap-
tive coping skills were not assessed in our material either
but would have been of interest as well.
The majority of variables were based on self-report, as
usual in large epidemiological studies. A trend for over-
estimation of physical activity [57] is possible and may
dilute an association between physical inactivity and FM
symptoms. Self-estimated sleep is not as reliable as an
objective measurement [58] but is valuable as a reflec-
tion of subjective experience [59], and is predictive of
morbidity and mortality [60]. Pain ratings are always
subjective.
Conclusions
Headache, back and neck pain, sleeping problems, and
high BMI were predictors of FM symptoms, predictors
which may be connected. Sleeping problems and high
BMI were influenced by familial factors. The intensity
and persistence of regional pain was associated with
increased risk for FM symptoms.
Heritability plays an important role in FM symptoms,
but also in many of the predictors. Therefore that headache
and regional pain are predictors independent of family
background is an important finding. Further studies must
evaluate possibilities of preventing FM by treatment and
management of such predictors.
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